x

Growing companies with advanced AI

SAIGroup is a private investment firm investing in businesses with the potential to become leaders in enterprise AI solutions. SAIGroup’s investments enable our portfolio companies to accelerate their innovation and growth. Principal owner and investor Dr. Romesh Wadhwani has made a commitment to invest up to $ 1 billion in SAIGroup.

Contact Us
Investment Focus

Investments in enterprise software companies

Control and minority investments in companies that have commercialized, high-value AI solutions with rapid deployment, innovative technology, and a referenceable customer base

Learn More
Unique Approach

Blending agility, flexibility, and expertise to catalyze value

SAIGroup provides the capital and deep business expertise essential for growth. Proven operational strategies couple with deep vertical and horizontal domain experience to drive growth through innovation, technology, talent, and go-to-market functions.

See our approach
Leading Portfolio

Building leaders in enterprise AI software

In five years, SAIGroup has become one of the largest, fastest-growing players in enterprise AI by building two leading businesses, SymphonyAI and ConcertAI. Together, these companies are approaching $500 million in revenue in 2022, growing ARR over 30% annually, and employing nearly 3,000 people worldwide.

view portfolio

Founder, Chairman, and CEO Romesh Wadhwani on SAIGroup’s Mission

Watch Video

SAIGroup

The SAIGroup portfolio comprises three rapidly growing enterprise AI software companies serving the needs of key verticals. We seek acquisitions and control investments for these three operating businesses and at the SAIGroup level.

View Portfolio
SymphonyAI

The leader in enterprise AI for key vertical sectors.

SymphonyAI is building the leading enterprise AI company for digital transformation across the most important and resilient growth verticals, including retail, CPG, financial services, manufacturing, media, and IT operations, with over 1,000 leading enterprises as clients. Since its founding in 2017, SymphonyAI has grown rapidly to nearly 2,000 talented leaders, data scientists, and other professionals.

Learn more about SymphonyAI
Financial Services
Industrial
Enterprise IT
Media
Retail/GPG
Trading and investing

Reimagine financial crime prevention

Conduct more efficient investigations and expertly manage risk by uniting the power of enterprise-grade technology with trailblazing AI

Visit

Redefine operations with AI-powered manufacturing

Generative and predictive AI platform and software to improve manufacturing processes, assist plant workers, optimize plant performance, and increase collaboration.

Visit

Transform IT and enterprise workflows with AI

An integrated IT and enterprise workflow automation platform built to enable the IT-led transformation of the enterprise.

Visit

Drive profitable growth with data-driven media insights

Manage, optimize, and predict content revenue for every model with data-driven intelligence for media and entertainment.

Visit

Connected retail for accelerated growth

Optimize supply chain performance, drive better category and space planning decisions, and deliver a personalized customer experience with breakthrough AI SaaS.

Visit

AI for trading and investing

Market leading analytics meets cutting-edge AI/ML to analyze financial and economic data and power complex modeling.

Visit
ConcertAI

The leader in real world data and enterprise AI for life sciences and healthcare.

ConcertAI is accelerating clinical drug development, improving image interpretation and clinical decision-making, and improving patient outcomes using advanced AI platforms and real world data from over 4 million patients. ConcertAI’s clients include 35 of the world’s top life sciences companies and more than 1,300 hospital systems globally. Since its founding in 2017, ConcertAI has grown rapidly to over 900 talented leaders, data scientists, and other professionals.

Learn more about ConcertAI
RWD products
Imaging
Digital/clinical trials
Predictive Patient
STAR

Real-World Data for Precision Evidence

ConcertAI’s rich suite of independent real-world data products are fit-for-purpose to meet a variety of research needs and use cases across the enterprise.

Visit

Imaging

Automate insights and improve patient care in radiology, cardiology, neurology, and more.

Visit

Digital/clinical trials

SaaS cloud solutions that provide integrated services for clinical trial design, sites, and clinical trial sponsors.

Visit Digital Trials Visit Clinical Trials

Improve Therapy Initiation and Adherence

Predictive Patient transforms millions of health and behavioral records, and applies advanced AI models to improve the patient experience from therapy initiation through adherence.

Visit

Enterprise, HIPAA-Compliant Solution for Actionable Patient Insights

Advanced AI algorithms and powerful data visualizations allow unique visibility into patient journey and adherence trends for optimized patient experiences and maximized brand value.

Visit
RhythmX AI

Rhythm X is revolutionizing primary care decision-making with AI-powered intelligence.

The world’s first native generative AI precision care platform for doctors to deliver hyper-personalized interventions and compassionate care

Visit
Get Well

Get Well provides high-quality personalized patient care by engaging patients, educating families, and empowering clinicians.

Get Well combines advanced AI navigation with high-touch care experiences to improve patient activation, loyalty, and outcomes and reduce the cost of care. Get Well serves more than 10 million patients annually at over 1,000 hospitals and clinical partner sites, using longitudinal data analytics to better serve patients and clinicians.

Visit
Financial Services
Industrial
Enterprise IT
Media
Retail/GPG
Trading and investing

Reimagine financial crime prevention

Conduct more efficient investigations and expertly manage risk by uniting the power of enterprise-grade technology with trailblazing AI

Visit

Redefine operations with AI-powered manufacturing

Generative and predictive AI platform and software to improve manufacturing processes, assist plant workers, optimize plant performance, and increase collaboration.

Visit

Transform IT and enterprise workflows with AI

An integrated IT and enterprise workflow automation platform built to enable the IT-led transformation of the enterprise.

Visit

Drive profitable growth with data-driven media insights

Manage, optimize, and predict content revenue for every model with data-driven intelligence for media and entertainment.

Visit

Connected retail for accelerated growth

Optimize supply chain performance, drive better category and space planning decisions, and deliver a personalized customer experience with breakthrough AI SaaS.

Visit

AI for trading and investing

Market leading analytics meets cutting-edge AI/ML to analyze financial and economic data and power complex modeling.

Visit
RWD products
Imaging
Digital/clinical trials
Predictive Patient
STAR

Real-World Data for Precision Evidence

ConcertAI’s rich suite of independent real-world data products are fit-for-purpose to meet a variety of research needs and use cases across the enterprise.

Visit

Imaging

Automate insights and improve patient care in radiology, cardiology, neurology, and more.

Visit

Digital/clinical trials

SaaS cloud solutions that provide integrated services for clinical trial design, sites, and clinical trial sponsors.

Visit Digital Trials Visit Clinical Trials

Improve Therapy Initiation and Adherence

Predictive Patient transforms millions of health and behavioral records, and applies advanced AI models to improve the patient experience from therapy initiation through adherence.

Visit

Enterprise, HIPAA-Compliant Solution for Actionable Patient Insights

Advanced AI algorithms and powerful data visualizations allow unique visibility into patient journey and adherence trends for optimized patient experiences and maximized brand value.

Visit

Our Culture, Values and Approach

SAIGroup and its portfolio companies share four key common values.
CUSTOMER CENTRIC

Deliver the highest value in months, not years

GROWTH THROUGH INNOVATION

Invest in new breakthrough products and solutions

FOCUS ON TALENT

Attract and retain the best talent

HIGH PERFORMANCE CULTURE

Emphasis on urgency, teamwork, results

Expert Team

Transforming companies with deep vertical expertise

Dr. Romesh Wadhwani

Founder, Chairman, and CEO

Read Bio

Dr. Romesh Wadhwani is the founder, chairman, and CEO of SAIGroup, a fast-growing operating group of leading AI companies that deliver a new generation of advanced AI solutions to transform the enterprise. SAIGroup companies focus on driving revenue growth and operational excellence for customers in their vertical sectors, including retail, CPG, life sciences, payer/provider, manufacturing and process industries, defense, financial services, and media.

Prior to founding SAIGroup, Dr. Wadhwani was the founder and CEO of Symphony Technology, a strategic private equity firm that builds great software and technology-enabled services companies. Dr. Wadhwani founded STG in 2002, growing it from startup to $ 2.5 billion in combined revenue and 15,000 employees. Dr. Wadhwani was the founder and CEO of Aspect Development Inc., a B2B software firm. Aspect Development was acquired in 2000 for $9.3 billion, the largest software acquisition at the time.

Dr. Wadhwani established the Wadhwani Foundation in 2001 to accelerate job creation and economic development in India and other emerging economies through large scale initiatives in entrepreneurship, innovation, and skilling. Today, the Wadhwani Foundation is active in India and more than 20 countries across Asia, Africa, and Latin America.

Wadhwani Advantage, Wadhwani Entrepreneur, and Wadhwani Innovate are three large initiatives for helping hundreds of entrepreneurs start new businesses and grow existing SME businesses each year, creating a large number of new jobs. The Wadhwani Advantage initiative allows tens of thousands of students each year learn employability and soft skills and get placed in high-quality jobs.

Dr. Wadhwani and his brother Sunil Wadhwani have established the Wadhwani Institute for AI for Social Good in Mumbai, a research institute and global hub for developing AI solutions for social good in public health, education, skilling, job creation, and infrastructure. Indian Prime Minister Modi inaugurated WIAI in 2018. The institute was awarded the Google Prize in 2019 for one of its innovative initiatives.

In January 2020, the Government of India awarded Dr. Wadhwani the Padma Shri honor, the fourth-highest civilian award in the Republic of India. President Barack Obama appointed Dr. Wadhwani to the board of trustees for the John F. Kennedy Center. Dr. Wadhwani is a board member of the Center for Strategic and International Studies in Washington, DC and is a member of the Gates Buffet Giving Pledge.

Dr. Wadhwani holds a bachelor of science degree in electrical engineering from the Indian Institute of Technology Bombay and a master’s of science and Ph.D. in electrical engineering from Carnegie Mellon University. Dr. Wadhwani received an honorary doctorate from the Indian Institute of Technology Bombay in August 2018.

Pradyut Shah

Senior Investment Partner

Read Bio

Pradyut Shah is a senior investment partner at SAIGroup and oversees all investment and acquisition activity at the firm. He has led several the acquisitions of several companies at SAIGroup, notably the acquisitions of Get Well, CancerLinQ, 1010data, NetReveal, Proceedix, ReTech Labs, Savigent, TeraRecon, Azima, Ayasdi, and MAI.

Pradyut was previously a Managing Director and founding member of Insignia Capital Group, a middle-market private equity firm where he served as a Director on the Boards of portfolio companies in the consumer sector. Prior to Insignia, he was a Vice President at Behrman Capital where he was significantly involved with a number of private equity investments from 2004 to 2011, including Athena Diagnostics, Brooks Equipment Company, Peacock Engineering Company, Pelican Products and WIL Research Laboratories. Prior to Behrman, Pradyut spent 3 years at Credit Suisse First Boston’s Technology Group.

He attended the Jerome Fisher Program in Management & Technology at the University of Pennsylvania, where he graduated summa cum laude with a B.S.E. in Computer Science from the School of Engineering and Applied Science and a B.S. in Economics with a major in Finance from the Wharton School of Business.

Michael Healy

Senior Investment Partner

Read Bio

Mike Healy is a senior investment partner at SAIGroup. He is responsible for investment and acquisition activity across healthcare and other vertical sectors.

Mike has focused on investing in high-growth healthcare companies since 2012. He previously was co-managing partner of Bailey & Company’s Principal Investing and managing partner at Healy Capital Partners. Prior to founding Healy Capital, Mike was a partner at TT Capital Partners, the private equity arm of TripleTree. Before TTCP, Mike was a director at Norwest Equity Partners where he focused on management buyouts, recapitalizations, and growth investments across a variety of industries. Earlier in his career, Mike worked in corporate development at Wells Fargo & Co. and Arthur Andersen in a transaction advisory services role.

Mike holds a bachelor’s degree in accounting from the University of Notre Dame.

Eshwar Belani

Operating Partner

Read Bio

Eshwar Belani is an accomplished executive and a pioneer in the AI and technology space. He has a proven track record in transforming innovative ideas into ground-breaking products and services, fueling exponential growth, and reshaping the business landscape.

Eshwar is currently a founding partner at SAIGroup, where he identifies strategic investment opportunities and works with portfolio companies to spur innovation and growth.

Before SAIGroup, he held pivotal roles in several successful ventures. At Rubrik, he was instrumental in launching an innovative suite of IT infrastructure products, propelling the company to an annual run rate of $100M in just six quarters. As a founding executive at Rocket Fuel, his contributions were instrumental in the company’s meteoric rise from a start-up to earning over $400M in annual revenue and clinching the #1 spot on Deloitte’s Technology Fast 500™ list.

Earlier in his career, Eshwar founded Sensact Applications, focusing on IoT solutions, and iLeverage, which was acquired by Epiphany, where he later worked on its flagship CRM marketing and analytics platforms.

Eshwar serves as an advisor to emerging companies nurtured by Singularity University and Alchemist Accelerator. He’s also a charter member of TiE Silicon Valley. His academic accomplishments include a bachelor’s of technology degree from IIT Madras, a master’s degree in computer science and management of technology degree from U.C. Berkeley. He has authored several academic publications and holds six patents.

Deepthi Bathina

CEO and Founder, RhythmX AI

Read Bio

Deepthi Bathina is the founder and CEO of RhythmX AI, with $50M initial investment from SAIGroup. RhythmX AI is a generative AI-native health company driving a paradigm shift in hyper-personalized care. RhythmX AI’s precision care platform helps physicians pioneer a new era of whole-person care through generative and predictive AI-powered copilots.

Deepthi is chair of the board of the Kerry Murphy Healey Center for Health Innovation and Entrepreneurship at Babson College. She is the former chief product officer of Humana. She led Humana’s evolution to a product, service, and experience focus while overseeing the product design, development, and delivery for chronic condition management, behavioral health, social determinants of health, caregiver solutions, utilization management, care management, oncology, musculoskeletal and pharmacy areas across Medicare, Medicaid, and commercial segments. She also led customer success organizations at Humana, responsible for winning new business, implementations, and overall customer satisfaction. Humana is a Fortune 50 market leader in integrated healthcare serving over 16 million medical members, including over 6 million TriCare members.

Before Humana, Deepthi was general manager of operations for the approximately $1B Healthcare Technology Division of Nuance Communications, the market leader in AI-powered solutions serving more than 450,000 clinicians at more than 10,000 healthcare institutions worldwide. She is also the former COO of the clinical decision support division (UpToDate) at Wolters Kluwer, where she led product management, technology and engineering, global customer operations, implementations, and global IT infrastructure in 170 countries.

Deepthi has also held leadership positions in innovative companies ranging from Fortune 500, such as ADP, to start-ups. Former GE CEO Jack Welch directly chose her as his strategy consultant. In this role, Deepthi initiated and executed several strategic initiatives that influenced millions of business leaders and entrepreneurs worldwide.

She holds a master’s degree in computer science from Worcester Polytechnic Institute and an MBA from Babson College Graduate School of Business.

Jimmy Sourbeer

Principal, Investment Team

Read Bio

Jimmy Sourbeer is a principal on the SAIGroup investment team. His responsibilities include sourcing, evaluating, and executing acquisitions. Jimmy was previously a vice president at Resurgens Technology Partners, a lower middle-market private equity firm focused on software and tech-enabled services businesses. Prior to Resurgens, Jimmy was a vice president at PGi, where he assisted in leading the execution of strategic investments, deploying over $175 million in four acquisitions. Prior to PGi, Jimmy was an associate at ICG, where he was involved in identifying and investing in software businesses. He began his career in investment banking.

Jimmy holds a bachelor’s of arts degree in economics from Northwestern University and an MBA from Columbia Business School, where he was a member of the Private Equity Fellows program, received the Robert H. Montgomery Prize in accounting, and graduated with Dean’s Honors.

Jimmy is based in Los Altos, CA, and can be reached at Jsourbeer@symphonyai.com

Jason Williams

Principal, Investment Team

Read Bio

Jason Williams is a senior associate for SAIGroup, focused on executing acquisitions across several verticals. Prior to joining SAIGroup in 2018, Jason worked as an investment professional at Golden Gate Capital and at The Gores Group, where he focused on investments in the industrial and technology sectors. Previously, he worked as a consultant in the Dallas office of the Boston Consulting Group, where he conducted numerous projects in the technology media and telecom industries.

Jason has a bachelor degree in neurobiology with a secondary degree in economics from Harvard College.

Michael Cashin

Managing Director, Head of Business Development

Read Bio

Mike is a director and head of business development for SAIGroup. He is responsible for all aspects of deal origination and qualification. Before joining SAIGroup, Mike was the head of corporate development for ESW Capital, a $2 billion private investment firm focused on enterprise software acquisitions.

Previously, Mike was a member of the business development team and led the technology efforts at OpenGate Capital. Mike began his career in private equity as an associate with Pegasus Capital Group.

Mike holds an MBA with a focus in finance and entrepreneurial management from Pepperdine Graziadio Business School and a bachelor’s of science degree in business administration from Pepperdine University.

Mike is based in Los Angeles and can be reached at mcashin@symphonyai.com.

Nick Balay

Vice President, Investment Team

Read Bio

Nick Balay is a vice president on the SAIGroup investment team, responsible for sourcing, evaluating, and executing acquisitions across healthcare and other vertical sectors.

Prior to joining SAIGroup in 2022, Nick was a project leader in the Minneapolis office of the Boston Consulting Group, where he served healthcare, public sector, industrial goods, and private equity clients on various topics, including strategy, data & analytics, organization design, and buy-side due diligence. Previously, he worked in corporate development at Optum/UnitedHealth Group where he evaluated and executed M&A transactions in healthcare information technology, services, and delivery.

Nick earned his MBA with high honors from the University of Chicago Booth School of Business. He also holds a bachelor’s degree in economics from the University of Chicago with a minor in Near Eastern languages and civilizations.

Malik Gill

Senior Investment Associate

Read Bio

Malik is a senior associate on the SAIGroup investment team, focused on evaluating and executing acquisitions. Prior to joining SAIGroup in 2021, Malik was an investment banking associate at GCA Advisors where he worked on M&A transactions in the software, advertising technology, financial technology, and tech-enabled services sectors. Previously, Malik worked at Beacon Tree Capital LLC as an analyst and Cisco Systems Inc. in corporate development.

Malik holds a bachelor’s degree in economics from Harvard College.

Stephen Harris

Equity Research Analyst

Read Bio

Stephen Harris is an equity research analyst on the SAIGroup investment team. His responsibilities include conducting fundamental research and formulating strategy for SAIGroup’s public markets investment strategy, with a strong focus on technology, software, and AI. In addition, Stephen also assists the team with select projects related to SAIGroup’s portfolio of enterprise AI companies.

Stephen was previously a senior equity research associate at Capital Group. Before that, he was an equity research analyst at MayTech Global Investments, focusing on global growth investments in technology, healthcare, and payments. Before that, Stephen was a valuation analyst at Adams Capital and a research associate at Gerson Lehrman Group (GLG).

Stephen holds a bachelor’s degree in economics, with minors in mathematics and computer science, from Emory University.

Senjie Wang

Investment Associate

Read Bio

Senjie is an associate on the SAIGroup investment team, responsible for evaluating and executing acquisitions. Prior to joining SAIGroup, Senjie was an investment banking analyst at Needham & Company, where he worked on M&A transactions in the software, internet, digital media, and consumer technology sectors. Previously, Senjie worked at Macquarie Capital as an investment banking analyst.

Senjie holds a bachelor’s degree in economics and statistics from the University of California, Berkeley.

Alex Essig

Investment Associate

Read Bio

Alex is an associate on the SAIGroup investment team, responsible for evaluating and executing acquisitions. Prior to joining SAIGroup, Alex was promoted from analyst to associate at Goldman Sachs in the healthcare investment banking group, where he worked on M&A, equity, and debt transactions. Alex previously interned at Graham Partners, a middle-market private equity firm investing in advanced manufacturing companies.

Alex graduated summa cum laude with a bachelor’s degree in international affairs and public policy from Princeton University.

Adeel Warraich

Investment Associate

Read Bio

Adeel is an associate on the SAIGroup investment team, responsible for evaluating and executing acquisitions. Prior to joining SAIGroup, Adeel was an analyst in Houlihan Lokey’s investment banking division where he worked on M&A transactions in the industrials sector. Previously, Adeel worked in SVB Securities’ technology investment banking group where he primarily focused on transactions in the software sector.

Adeel holds a bachelor’s degree in economics from the University of Texas at Austin.

Alec Pisanelli

Investment Associate

Read Bio

Alec is an associate on the SAIGroup investment team, focused on evaluating and executing acquisitions. Prior to joining SAIGroup, Alec was an associate in Citigroup’s investment banking division where he worked on M&A, debt, and equity transactions in sectors including software, internet, consumer technology and property technology sectors. Previously, Alec worked in Citigroup’s debt capital markets group, advising on corporate financings in technology, media, and telecommunications markets.

Alec graduated summa cum laude with a bachelor’s degree in finance from the University of Connecticut, School of Business.

Alec can be reached at alec.pisanelli@saigroup.ai.